News tagged with experimental therapeutics
World's first delivery of intra-arterial Avastin directly into brain tumor
Nov 17, 2009 |
5 / 5 (2) |
0
Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. This novel ...
Mount Sinai leads unprecedented attempt to discover rules for assembling human tissue
Sep 24, 2009 |
not rated yet |
0
Researchers from Mount Sinai School of Medicine and two other academic institutions have received federal funding to systematically assemble functional human kidney tissue from tissue modeled on a computer. If successful, ...
Finding of genetic region controlling cardiovascular sensitivity to anesthetic propofol
Sep 10, 2009 |
not rated yet |
0
Researchers at The Medical College of Wisconsin in Milwaukee have identified the genetic region in rats responsible for cardiovascular collapse during anesthesia. While it is well known that people have different cardiovascular ...
First compound for receptors in schizophrenia and Alzheimer's holds promise
Apr 20, 2009 |
4 / 5 (1) |
0
For almost 20 years, pharmacological companies have known that certain compounds that activate two specific CNS receptors, causing them to release the neurotransmitter acetylcholine, are effective in treating the cognitive ...
Search results for experimental therapeutics
THC exposure as adolescents linked to negative effects of THC as adults
Apr 19, 2009 |
3.5 / 5 (2) |
0
In earlier studies, researchers at Louisiana State University had found that estrogen - or more precisely, having ovaries - made adult rats exposed for the first time to THC, the primary ingredient in marijuana and hashish, ...
Appealing the death sentence for brain cells
May 29, 2008 |
5 / 5 (5) |
0
A new drug candidate discovered by Tel Aviv University researcher Prof. Illana Gozes may lead to an effective treatment against the debilitative Alzheimer's disease. This compound could also treat a number of diseases where ...
Improved rodent trials can speed cancer drug development
Oct 28, 2008 |
not rated yet |
0
Better design of rodent trials could reduce the cost and time required for cancer drug development, according to a commentary in the October 28 online issue of the Journal of the National Cancer Institute.
Personalized immunotherapy to fight HIV/AIDS
Medicine & Health / HIV & AIDS
Aug 15, 2008 |
4 / 5 (6) |
0
For a long time, the main obstacle to creating an AIDS vaccine has been the high genetic variability of the HIV virus. Dr. Jean-Pierre Routy and his team from the Research Institute of the McGill University Health Centre ...
Novel treatments and current clinical trials for Alzheimer's disease therapies show promise
Oct 23, 2008 |
5 / 5 (1) |
0
The past 25 years have seen an explosion of scientific investigations into the basic neurobiology of Alzheimer's disease (AD). Unfortunately, the gap between bench and bedside remains as vast as ever. Recent progress, however, ...
Dismissed leukemia drug helps CLL patients, studies show
Medicine & Health / Medications
Dec 08, 2008 |
4.9 / 5 (8) |
0
Researchers at Ohio State devised a new dosing schedule for the drug to increase its anti-tumor activity.
Experimental insulin-like growth factor receptor inhibitor reduced pancreatic cancer growth
Apr 14, 2009 |
not rated yet |
0
Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a ...
Obesity predisposition traced to the brain's reward system
Jul 29, 2008 |
4.6 / 5 (9) |
0
The tendency toward obesity is directly related to the brain system that is involved in food reward and addictive behaviors, according to a new study. Researchers at Tufts University School of Medicine (TUSM) and colleagues ...
Blueberry and green tea containing supplement protects against stroke damage
Mar 04, 2008 |
3.5 / 5 (11) |
0
A unique dietary supplement called NutraStem has been shown to have beneficial effects following experimental stroke. A nutritional supplement product, NutraStem also known as NT-020, is a proprietary formulation of blueberry, ...
Study validates means to measure possible leukemia marker
Apr 30, 2009 |
not rated yet |
0
A study led by cancer researchers at The Ohio State University has validated a method for reliably measuring variations in certain proteins that may make good biomarkers in chronic leukemia patients.
List of search results for experimental therapeutics
